Intervention Effect of High-Definition Transcranial Alternating Current Stimulation (HD-tACS) on Non-suicidal Self-injury (NSSI)
Anhui Medical University
40 participants
May 1, 2023
INTERVENTIONAL
Conditions
Summary
To investigate the intervention effect of high-definition transcranial alternating current stimulation (HD-tACS) on patients with Non-suicidal Self-injury (NSSI) and its underlying neural mechanism by magnetic resonance imaging (MRI).
Eligibility
Inclusion Criteria3
- The patients were diagnosed by 2 or more senior clinical psychiatrists, meeting DSM-V criteria, and having 1 or more non-suicidal self-injurious behaviors in the last 6 months.
- -18 years of age.
- The medicine has not changed in the 4 weeks prior to or after this study, and if it has to be changed, the treatment medication is required to be at a subtherapeutic dosage level.
Exclusion Criteria7
- The patient has suicidal ideation or has committed suicidal behavior
- T1 or T2 weighted phase magnetic resonance images show focal brain lesions
- patients had neurological disorders such as epilepsy, or serious physical illnesses
- patients had a history of substance abuse and drug dependence in the last 6 months or use of anticonvulsant drugs in the last 3 months
- patients had received radial cranial electrical stimulation or magnetic stimulation treatment in the last 3 months or received electroconvulsive therapy in the last 6 months
- patients had previous significant head trauma or EEG abnormality in the last 1 month
- body-mounted devices unsuitable for treatment, such as pacemakers, artificial valves, and other metal implants.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
tACS is described as a non-invasive form of brain stimulation that uses a low-intensity, alternating current applied directly to the head through scalp electrodes.
In the sham condition, tACS was delivered only during the ramp-up and ramp-down periods (15s and 15s); no current was delivered during the 20-minute intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06127056